Glucosteril

Glucosteril is a sterile intravenous solution containing glucose monohydrate as the active ingredient; the strength is not specified. It is supplied as a solution for injection and is marketed in the European Union. The product is classified as an excipient/solvent and is used under prescription for clinical situations that require rapid carbohydrate delivery and fluid replacement.

Glucosteril is employed in medical settings where immediate glucose provision and fluid balance are needed.

- Treatment of acute hypoglycemia in adults and children - Component of parenteral nutrition regimens - Fluid and electrolyte replenishment during dehydration - Intra‑operative glucose support for surgical patients - Maintenance of glucose levels in neonatal intensive care - Emergency care for patients with low blood glucose due to trauma or illness

Glucosteril may be associated with both mild and more serious adverse reactions.

Common: - Mild hyperglycemia - Local irritation or pain at the intravenous site - Transient peripheral edema - Nausea or mild gastrointestinal discomfort - Temporary increase in serum osmolality - Mild electrolyte shifts (e.g., potassium)

Serious: - Severe hyperglycemia requiring medical intervention - Significant electrolyte imbalance (e.g., severe hypokalemia) - Anaphylactic or severe allergic reaction - Volume overload leading to pulmonary edema - Acute renal dysfunction in susceptible patients - Life‑threatening hyperosmolar state

Safety considerations are essential when administering Glucosteril.

- Monitor blood glucose levels frequently during infusion - Assess fluid status and avoid excessive volume administration - Use caution in patients with renal, cardiac, or hepatic impairment - Adjust dosing for pediatric or neonatal patients under professional guidance - Verify compatibility with other intravenous solutions and catheters - Review pregnancy and lactation status before use - Discontinue if signs of severe hyperglycemia or allergic reaction appear

Glucosteril can interact with other medications and solutions administered intravenously.

Avoid: - Co‑administration of additional high‑dose dextrose or glucose solutions - Insulin overdose or mismatched insulin dosing - Medications that cause marked hypokalemia (e.g., high‑dose diuretics) - Hyperosmolar agents that may exacerbate fluid shifts

Use with caution: - Loop or thiazide diuretics affecting electrolyte balance - Beta‑blockers that may mask hypoglycemia symptoms - Corticosteroids that increase glucose production - Vasopressors influencing circulatory dynamics - Other intravenous fluids requiring careful volume management